Keywords: amiodarone; dronedarone; flecainide; peripheral neuropathy; propafenone; sotalol;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Atrioventricular block; Ventricular tachycardia/ventricular fibrillation; Myocardial infarction; Left ventricular systolic dysfunction; Flecainide;
Keywords: atrial fibrillation; Flecainide; Pilsicainide; Quality of life; Symptomatic;
Keywords: Atrial fibrillation; Pharmacological cardioversion; Flecainide; Hemodynamic failure; Vasovagal reaction;
Keywords: Brugada syndrome; Sodium-channel blocker challenge; Ajmaline; Flecainide; Complication;
Keywords: Flecainide; Overdose;
Keywords: Pacemaker malfunction; Failure to capture; Flecainide; Overdose; Use-dependent block;
Keywords: Supraventricular tachycardia; Wolff-Parkinson-White syndrome; Flecainide; Incessant orthodromic AV reentrant tachycardia; Proarrhythmia;
Keywords: Fetal supraventricular tachycardia; Flecainide; Fetal hydrops; Fetal heart failure; Digoxin; Fetal arrhythmia
Keywords: Early repolarization syndrome; Ventricular fibrillation; Flecainide;
Keywords: IV; intravenous; VA-ECMO; venoarterial extracorporeal membrane oxygen; VT; ventricular tachycardia; Flecainide; Overdose; Arrhythmia; Extracorporeal membrane oxygenation; Mechanical circulatory support;
Keywords: BrS; Brugada syndrome; ECG; electrocardiogram/electrocardiographic; Het-EM; heterozygous extensive metabolizer; Hom-EM; homozygous extensive metabolizer; QTc; corrected QT; SD; sudden death; Brugada syndrome; Electrocardiogram; Provocative testing; Flecai
Keywords: AET; atrial ectopic tachycardia; AV; atrioventricular; ECG; electrocardiogram; PJRT; permanent junctional reciprocating tachycardia; SVT; supraventricular tachycardia; VA; ventriculoatrial; Fetus; Arrhythmia; Supraventricular tachycardia; Flecainide;
Initiation and outcomes with Class Ic antiarrhythmic drug therapy
Keywords: Atrial fibrillation; Antiarrhythmic medication; Flecainide; Propafenone; Exercise stress testing; Proarrhythmia;
Class IC antiarrhythmic drugs for suspected premature ventricular contraction-induced cardiomyopathy
Keywords: Cardiomyopathy; Class IC antiarrhythmic drug; Flecainide; Premature ventricular contraction; Premature ventricular contraction-induced cardiomyopathy; Propafenone;
Multifocal atrial and ventricular premature contractions with an increased risk of dilated cardiomyopathy caused by a Nav1.5 gain-of-function mutation (G213D)
Keywords: AF; atrial fibrillation; DCM; dilated cardiomyopathy; ECG; electrocardiogram; EPS; electrophysiological study; LA; left atrium; LV; left ventricle; LVEF; left ventricular ejection fraction; MEPPC; multifocal ectopic Purkinje-related premature contractions
Intravenous Flecainide for Emergency Department Management of Acute Atrial Fibrillation
Keywords: atrial fibrillation; recent onset; cardioversion; flecainide;
Clinical effectiveness of a systematic “pill-in-the-pocket” approach for the management of paroxysmal atrial fibrillation
Keywords: Atrial fibrillation; Antiarrhythmic; Cardioversion; Flecainide; Propafenone;
Probing flecainide block of INa using human pluripotent stem cell-derived ventricular cardiomyocytes adapted to automated patch-clamping and 2D monolayers
Keywords: AP; action potential; APD; action potential duration; EAD; early after-depolarization; EP; electrophysiology; ESCs; embryonic stem cells; FLE; flecainide; hESC; human embryonic stem cell; hPSC; human pluripotent stem cell; hPSC-CMs; human pluripotent stem
Eleclazine, an inhibitor of the cardiac late sodium current, is superior to flecainide in suppressing catecholamine-induced ventricular tachycardia and T-wave alternans in an intact porcine model
Keywords: Late sodium current; T-wave alternans; Catecholamines; Ventricular tachycardia; Flecainide; Eleclazine; Epinephrine;
Flecainide and elevated liver enzymes in α1-antitrypsin deficiency
Keywords: Atrial fibrillation; Flecainide; Cardiovascular disease; Liver toxicity; Drug adverse event;
Antiarrhythmic effect of vernakalant in electrically remodeled goat atria is caused by slowing of conduction and prolongation of postrepolarization refractoriness
Keywords: Vernakalant; Atrial fibrillation; Remodeling; Antiarrhythmic drugs; In vivo model; Flecainide; AVE0118;
High-dose flecainide with low-dose β-blocker therapy in catecholaminergic polymorphic ventricular tachycardia: A case report and review of the literature
Keywords: Catecholaminergic polymorphic ventricular tachycardia; Beta blocker; Compliance; Flecainide; Sudden cardiac death
Serum flecainide S/R ratio reflects the CYP2D6 genotype and changes in CYP2D6 activity
Keywords: Flecainide; S/R ratio; CYP2D6; Genotype; CYP2D6 inhibitor
Flecainide in Amyotrophic Lateral Sclerosis as a Neuroprotective Strategy (FANS): A Randomized Placebo-Controlled Trial
Keywords: Flecainide; Amyotrophic lateral sclerosis; Sodium channel; Neuroprotection
Synergistic antiarrhythmic effect of combining inhibition of Ca2+-activated K+ (SK) channels and voltage-gated Na+ channels in an isolated heart model of atrial fibrillation
Keywords: ACh; acetylcholine; aERP; atrial effective refractory period; AF; atrial fibrillation; APD; action potential duration; ICA; N-(pyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine; MAP; monophasic action potential; SK; small conductance Ca2+-activated K+; STV; s
Molecular basis of hERG potassium channel blockade by the class Ic antiarrhythmic flecainide
Keywords: Flecainide; hERG; QT interval; Repolarization; Torsades de Pointes;
Vernakalant activates human cardiac K2P17.1 background K+ channels
Keywords: AF; atrial fibrillation; APD; action potential duration; CHO; Chinese hamster ovary; K2P; two-pore-domain K+ channel; SR; sinus rhythm; TALK; TWIK-related alkaline pH-activated K+ channel 2; TASK; TWIK-related acid-sensitive K+ channel; THIK; tandem pore
Pharmacokinetic-pharmacodynamic modeling of QRS-prolongation by flecainide: Heart rate-dependent effects during sinus rhythm in conscious telemetered dogs
Keywords: Flecainide acetate (PubChem CID: 41022); Nav1.5; QRS; Flecainide; Modeling; Pharmacokinetics; Electrocardiogram; Beagle dog;
Inhibition of cardiac two-pore-domain K+ (K2P) channels by the antiarrhythmic drug vernakalant – Comparison with flecainide
Keywords: Antiarrhythmic drug; Atrial fibrillation; Cardiac arrhythmia; Flecainide; K2P channel; Vernakalant
Oral flecainide is effective in management of refractory tachycardia in infants
Keywords: Flecainide; Tachycardia; Digoxin
Flecainide reduces ventricular arrhythmias via a mechanism that differs from that of β-blockers in catecholaminergic polymorphic ventricular tachycardia
Keywords: Flecainide; β-blocker; Catecholaminergic polymorphic ventricular tachycardia; Exercise-stress test; Ryanodine receptor 2
Spinal blockades of class I antiarrythmic drugs with bupivacaine by isobolographic analysis in rats
Keywords: Flecainide; Quinidine; Mexiletine; Bupivacaine; Spinal blockades; Isobolographic analysis
Toward specific cardiac IK1 modulators for in vivo application: Old drugs point the way
Keywords: Chloroquine; Flecainide; Heart; Inward rectifier; Kir2.1; Kir2.2; Kir2.3; AF; atrial fibrillation;
Class I antiarrhythmic drugs produced a spinal anesthetic effect in rats
Keywords: Antiarrhythmic; Quinidine; Mexiletine; Flecainide; Spinal anesthesia;
Acquired long QT syndrome and ventricular tachycardia in a patient on flecainide therapy
Keywords: Flecainide; Long QT syndrome; Ventricular tachycardia
A novel mechanism for LQT3 with 2:1 block: A pore-lining mutation in Nav1.5 significantly affects voltage-dependence of activation
Keywords: Cardiac Sodium Channel; LQT3; V411M; Flecainide; Mexiletine; Lidocaine; WT; wild-type; LQTS; Long QT Syndrome; AP; action potential; ECG; electrocardiogram; GOF; gain of function; HEK; human embryonic kidney; TdP; torsades de pointes;
Efficacy and potency of class I antiarrhythmic drugs for suppression of Ca2+ waves in permeabilized myocytes lacking calsequestrin
Keywords: Catecholaminergic polymorphic ventricular tachycardia; Calsequestrin 2; Cardiac ryanodine receptor (RyR2) Ca2+ release channel; Class I antiarrhythmic drugs; Flecainide; R-propafenone
Antiarrhythmic use from 1991 to 2007: Insights from the Canadian Registry of Atrial Fibrillation (CARAF I and II)
Keywords: Atrial fibrillation; Antiarrhythmia agents; Flecainide; Propafenone; Sotalol; Quinidine; Amiodarone; Adrenergic beta-antagonists; Calcium channel blockers; Digoxin; Digitalis glycosides; TrendsAAD, antiarrhythmic drugs; AF, atrial fibrillation; BB, beta-b
Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass
Keywords: Calcium sparks; Flecainide; Tetracaine; RyR2; Catecholaminergic polymorphic ventricular Tachycardia
Diagnosis, evaluation and treatment of cardiac arrhythmias
Keywords: adenosine; amiodarone; atrioventricular node; beta-blockers; cardiac arrhythmia; digoxin; EGC; flecainide; genetics; radiofrequency ablation; tachycardia
Transvenous electrical cardioversion of atrial fibrillation in six horses using custom made cardioversion catheters
Keywords: Equine; Amiodarone; Quinidine sulfate; Flecainide; Direct-current shocks
Efectos de la flecainida sobre las velocidades de conducción longitudinal y transversal en el miocardio ventricular. Estudio experimental
Keywords: Flecainida; Velocidad de conducción; Miocardio ventricular; Flecainide; Conduction velocity; Ventricular myocardium;
A successfully novel ICD implantation and medical treatment in a child with LQT syndrome and self-limiting ventricular fibrillation
Keywords: Congenital long QT syndrome; Flecainide; Beta-blockers; ICD
Zastosowanie flekainidu w czÄstoskurczu nadkomorowym u noworodków i niemowlÄ
t
Keywords: flekainid; czÄstoskurcz nadkomorowy; noworodki; niemowlÄta; leczenie antyarytmiczne; flecainide; supraventricular tachycardia; newborns; infants; antiarrhythmic therapy;
Action potential experiments complete hERG assay and QT-interval measurements in cardiac preclinical studies
Keywords: Action potential; Cardiac safety pharmacology; Conduction; d,l-Sotalol; Flecainide; hERG current; NaV1.5 current; Quinidine; Rabbit atria; Rabbit Purkinje fibres
Class Ic antiarrhythmics block human skeletal muscle Na channel during myotonia-like stimulation
Keywords: Myotonia; Flecainide; Anti-arrhythmia agent; Sodium channel; Patch-clamp technique;
Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome
Keywords: Brugada syndrome; Arrhythmia; Electrocardiogram; Ajmaline; Flecainide;